Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 6/2001

01-12-2001 | Clinical and Epidemiological Study

Long-Term Seropositivity against Echinococcus multilocularis in an Epidemiological Follow-up Study in Southwestern Germany (Römerstein)

Authors: B. Jensen, S. Reuter, W. Kratzer, K. Naser, V. Kächele, P. Kimmig, P. Kern

Published in: Infection | Issue 6/2001

Login to get access
Metadata
Title
Long-Term Seropositivity against Echinococcus multilocularis in an Epidemiological Follow-up Study in Southwestern Germany (Römerstein)
Authors
B. Jensen
S. Reuter
W. Kratzer
K. Naser
V. Kächele
P. Kimmig
P. Kern
Publication date
01-12-2001
Publisher
Urban & Vogel Medien und Medizin Verlagsgesellschaft
Published in
Infection / Issue 6/2001
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-001-1153-3

Other articles of this Issue 6/2001

Infection 6/2001 Go to the issue

Brief Report

Nocardial Brain Abscess: Observation of Treatment Strategies and Outcome in Switzerland from 1992 to 1999

Clinical and Epidemiological Study

The Penetration of Ciprofloxacin into Human Pancreatic and Peripancreatic Necroses in Acute Necrotizing Pancreatitis

Correspondence

Evidence of HIV-2 Infection in Northern Italy

Case Report

Spontaneous Gram-Negative Cellulitis in a Liver Transplant Recipient

Case Report

Retroperitoneal Suppurative Lymphadenitis Complicating Staphylococcus aureus Acute Bacterial Endocarditis

Case Report

Reactivation of Hepatitis C Virus Superinfection in a Patient Seropositive for Hepatitis B e Antigen
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits